These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 24043737

  • 1. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
    Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB.
    J Clin Oncol; 2013 Oct 20; 31(30):3807-14. PubMed ID: 24043737
    [Abstract] [Full Text] [Related]

  • 2. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
    Hellesnes R, Kvammen Ø, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS.
    Int J Cancer; 2020 Jul 01; 147(1):21-32. PubMed ID: 31597192
    [Abstract] [Full Text] [Related]

  • 3. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
    Li H, Zhu C, Wu J, Ma Y, Jin X, Wei X, Wang K, Li H.
    Int Urol Nephrol; 2021 Mar 01; 53(3):471-477. PubMed ID: 33052518
    [Abstract] [Full Text] [Related]

  • 4. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD, Dores GM, Gilbert ES.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1354-65. PubMed ID: 16174857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
    Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB.
    J Clin Oncol; 2015 Oct 01; 33(28):3105-15. PubMed ID: 26240226
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE.
    J Clin Oncol; 2007 Oct 01; 25(28):4370-8. PubMed ID: 17906202
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M, Chen BE, Jaffe ES, Travis LB.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):215-22. PubMed ID: 17284716
    [Abstract] [Full Text] [Related]

  • 13. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
    Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M.
    J Clin Oncol; 2018 Aug 20; 36(24):2504-2513. PubMed ID: 29989856
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
    Vidal AD, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    Ann Oncol; 2015 Feb 20; 26(2):374-7. PubMed ID: 25392157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
    Pokrivcak T, Lakomy R, Kazda T, Poprach A, Fabian P, Kiss I.
    Medicine (Baltimore); 2021 Jun 18; 100(24):e26381. PubMed ID: 34128899
    [Abstract] [Full Text] [Related]

  • 17. Testicular cancer in 2013: towards personalized medicine--are we there yet?
    Oldenburg J, Fosså SD.
    Nat Rev Urol; 2014 Feb 18; 11(2):68-9. PubMed ID: 24366345
    [Abstract] [Full Text] [Related]

  • 18. Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors.
    Milano MT, Dinh PC, Yang H, Zaid MA, Fossa SD, Feldman DR, Monahan PO, Travis LB, Fung C.
    JNCI Cancer Spectr; 2020 Jun 18; 4(3):pkaa017. PubMed ID: 32455335
    [Abstract] [Full Text] [Related]

  • 19. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P.
    Cancer Causes Control; 2014 Jun 18; 25(6):659-68. PubMed ID: 24682745
    [Abstract] [Full Text] [Related]

  • 20. Second cancers after testicular cancer diagnosed after 1980 in Sweden.
    Hemminki K, Liu H, Sundquist J.
    Ann Oncol; 2010 Jul 18; 21(7):1546-1551. PubMed ID: 20019089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.